These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33305544)

  • 41. Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montréal, Canada: a descriptive analysis.
    Yang SS; Lipes J; Dial S; Schwartz B; Laporta D; Wong E; Baldry C; Warshawsky P; McMillan P; Hornstein D; de Marchie M; Jayaraman D
    CMAJ Open; 2020; 8(4):E788-E795. PubMed ID: 33234586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
    Cohen MA; Edelman A; Paynter R; Henderson JT
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.
    Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A;
    BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center].
    Schroeder I; Scharf C; Zoller M; Wassilowsky D; Frank S; Stecher SS; Stemmler J; Kneidinger N; Peterß S; Zwißler B; Irlbeck M
    Anaesthesist; 2021 Jul; 70(7):573-581. PubMed ID: 33369696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
    Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
    JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
    Yang JY; Parkins MD; Canakis A; Aroniadis OC; Yadav D; Dixon RE; Elmunzer BJ; Forbes N;
    JAMA Netw Open; 2021 Jan; 4(1):e2035699. PubMed ID: 33507259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.
    Kheir M; Saleem F; Wang C; Mann A; Chua J
    PLoS One; 2021; 16(3):e0248358. PubMed ID: 33725003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19).
    Metz TD; Clifton RG; Hughes BL; Sandoval G; Saade GR; Grobman WA; Manuck TA; Miodovnik M; Sowles A; Clark K; Gyamfi-Bannerman C; Mendez-Figueroa H; Sehdev HM; Rouse DJ; Tita ATN; Bailit J; Costantine MM; Simhan HN; Macones GA;
    Obstet Gynecol; 2021 Apr; 137(4):571-580. PubMed ID: 33560778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.
    Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J
    Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
    Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
    Patel NJ; Wang X; Lin M; Kowalski EN; Cook CE; Vanni KMM; Guzzo K; Qian G; Bade KJ; Saavedra A; Venkat R; Srivatsan S; Williams ZK; Hanberg JS; Kawano Y; Schiff AE; Sparks JA; Wallace ZS
    J Rheumatol; 2024 May; 51(5):529-537. PubMed ID: 38428964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex-Based Differences in COVID-19 Outcomes.
    Tejpal A; Gianos E; Cerise J; Hirsch JS; Rosen S; Kohn N; Lesser M; Weinberg C; Majure D; Satapathy SK; Bernstein D; Barish MA; Spyropoulos AC; Brown RM
    J Womens Health (Larchmt); 2021 Apr; 30(4):492-501. PubMed ID: 33885345
    [No Abstract]   [Full Text] [Related]  

  • 56. Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.
    Kompaniyets L; Goodman AB; Belay B; Freedman DS; Sucosky MS; Lange SJ; Gundlapalli AV; Boehmer TK; Blanck HM
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):355-361. PubMed ID: 33705371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study.
    Alpert N; Rapp JL; Marcellino B; Lieberman-Cribbin W; Flores R; Taioli E
    JNCI Cancer Spectr; 2021 Feb; 5(1):Pkaa085. PubMed ID: 33437923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
    Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA
    J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.